TY - JOUR
T1 - A simple scoring algorithm predicting extendedspectrum b-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia
AU - Lee, Chung Hsun
AU - Chu, Feng Yuan
AU - Hsieh, Chih Chia
AU - Hong, Ming Yuan
AU - Chi, Chih Hsien
AU - Ko, Wen Chien
AU - Lee, Ching Chi
N1 - Funding Information:
This study was partially supported by research grants from the Ministry of Science and Technology (NSC102-2314-B-006-079) and the National Cheng Kung University Hospital (NCKUH-10305018), Taiwan.
Publisher Copyright:
Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2017
Y1 - 2017
N2 - The incidence of community-onset bacteremia caused by extended-spectrum-β-lactamase (ESBL) producers is increasing. The adverse effects of ESBL production on patient outcome have been recognized and this antimicrobial resistance has significant implications in the delay of appropriate therapy. However, a simple scoring algorithm that can easily, inexpensively, and accurately be applied to clinical settings was lacking. Thus, we established a predictive scoring algorithm for identifying patients at the risk of ESBLproducer infections among patients with community-onset monomicrobial Enterobacteriaceae bacteremia (CoMEB). In a retrospective cohort,multicenter study, adults with CoMEBin theemergency department (ED)were recruited during January 2008 to December 2013. ESBL producers were determined based on ESBL phenotype.Clinical information was obtained fromchart records. Of the total 1141 adults with CoMEB, 65 (5.7%) caused by ESBL producers were identified. Four independent multivariate predictors of ESBL-producer bacteremia with high odds ratios (ORs) - recent antimicrobial use (OR, 15.29), recent invasive procedures (OR, 12.33), nursing home residents (OR, 27.77), and frequent ED user (OR, 9.98) - were each assigned +1 point to obtain the CoMEB-ESBL score. Using the proposed scoring algorithm, a cut-off value of +2 yielded a high sensitivity (84.6%) and an acceptable specificity (92.5%); the area under the receiver operating characteristic curve was 0.92. In conclusion, this simple scoring algorithm can be used to identify CoMEB patients with a high ESBL-producer infection risk. Of note, frequent ED user was firstly demonstrated to be a crucial predictor in predicting ESBL-producer infections. ED clinicians should consider adequate empirical therapy with coverage of these pathogens for patients with risk factors.
AB - The incidence of community-onset bacteremia caused by extended-spectrum-β-lactamase (ESBL) producers is increasing. The adverse effects of ESBL production on patient outcome have been recognized and this antimicrobial resistance has significant implications in the delay of appropriate therapy. However, a simple scoring algorithm that can easily, inexpensively, and accurately be applied to clinical settings was lacking. Thus, we established a predictive scoring algorithm for identifying patients at the risk of ESBLproducer infections among patients with community-onset monomicrobial Enterobacteriaceae bacteremia (CoMEB). In a retrospective cohort,multicenter study, adults with CoMEBin theemergency department (ED)were recruited during January 2008 to December 2013. ESBL producers were determined based on ESBL phenotype.Clinical information was obtained fromchart records. Of the total 1141 adults with CoMEB, 65 (5.7%) caused by ESBL producers were identified. Four independent multivariate predictors of ESBL-producer bacteremia with high odds ratios (ORs) - recent antimicrobial use (OR, 15.29), recent invasive procedures (OR, 12.33), nursing home residents (OR, 27.77), and frequent ED user (OR, 9.98) - were each assigned +1 point to obtain the CoMEB-ESBL score. Using the proposed scoring algorithm, a cut-off value of +2 yielded a high sensitivity (84.6%) and an acceptable specificity (92.5%); the area under the receiver operating characteristic curve was 0.92. In conclusion, this simple scoring algorithm can be used to identify CoMEB patients with a high ESBL-producer infection risk. Of note, frequent ED user was firstly demonstrated to be a crucial predictor in predicting ESBL-producer infections. ED clinicians should consider adequate empirical therapy with coverage of these pathogens for patients with risk factors.
UR - http://www.scopus.com/inward/record.url?scp=85018317232&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018317232&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000006648
DO - 10.1097/MD.0000000000006648
M3 - Article
C2 - 28422867
AN - SCOPUS:85018317232
SN - 0025-7974
VL - 96
JO - Medicine (United States)
JF - Medicine (United States)
IS - 16
M1 - e6648
ER -